SUNOL MOLECULAR
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.
Similar Organizations
AlphaSense
AlphaSense is a neurotechnology company, headquartered in Boston starting from 2013.
Anteros Pharmaceuticals
Anteros Pharmaceuticals is a biotechnology company that develops drugs for fibrotic and other inflammatory diseases.
AURA Biopharm
A new opportunity to find solutions for unmet medical needs and orphan diseases
Chromaderm
Chromaderm develops melanin production as therapy for skin brightening, melasma, and skin diseases associated with melanin production.
Imbioray
Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases.
MicroIslet
MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologes.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
ScandiBio Therapeutics
We develop metabolic co-factors that can be used in treatment of metabolic diseases.
Investors List
Techno Venture Management
Techno Venture Management investment in Venture Round - Sunol Molecular
More informations about "Sunol Molecular"
Sunol Molecular - Crunchbase Company Profile & Funding
Sunol Molecular is funded by Techno Venture Management. When was the last funding round for Sunol Molecular ? Sunol Molecular closed its last funding round on Jan 1, 2000 from a โฆSee details»
Sunol Molecular Corp. - Drug pipelines, Patents, Clinical trials
Last update 01 Nov 2024. Sunol Molecular Corp. Subsidiary Company |See details»
Sunol Molecular Corp - Company Profile and News
Company profile page for Sunol Molecular Corp including stock price, company news, executives, board members, and contact informationSee details»
Sunol Molecular Corporation | www.inknowvation.com
Sunol Molecular Corporation wasa biotechnology company focuses on the discovery, development, and commercialization of antibody-based therapeutics to treat disorders โฆSee details»
Sunol Molecular: Drug pipelines, Patents, Clinical trials - Synapse
Jul 22, 2023 Explore Sunol Molecular with its drug pipeline, therapeutic area, technology platform, 3 literature, Drug:Single chain T cell receptors (Sunol Molecular). Data. Feature. โฆSee details»
Sunol Molecular - Products, Competitors, Financials, Employees ...
About Sunol Molecular. Developer of antibody-based immunotherapeutic agents to treat disorders associated with the human tissue factor pathway. The company currently has under โฆSee details»
Sunol Molecular - Tech Stack, Apps, Patents & Trademarks
Organization. Sunol Molecular . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by โฆSee details»
Sunol Molecular Corporation - Products, Competitors, Financials ...
Sunol Molecular Corporation is a Healthcare/Biotechnology company based in Miramar, Florida. Use the CB Insights Platform to explore Sunol Molecular Corporation's full profile. Sunol โฆSee details»
Sunol Molecular - Crunchbase
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.See details»
Sunol Molecular Corp. - BioCentury Company Profiles - BCIQ
Jan 24, 2011 Sunol Molecular Corp. - BioCentury Company Profiles for the biopharma industrySee details»
Patents Assigned to Sunol Molecular Corporation
Aug 6, 2009 Applicants: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Sunol Molecular Corporation Inventors: Gerald W. Fischer, Richard F. Schuman, โฆSee details»
Single chain T cell receptors (Sunol Molecular) - Drug Targets ...
Single chain T cell receptors (Sunol Molecular), Initially developed by Sunol Molecular Corp., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms. ...See details»
Sunol Moves Sunol-cH36 Into Clinic; Fund-Raising In Works
Jun 19, 2003 Since the early 1990s, some employees of Sunol Molecular Corp. have been working in the area of tissue factor, even before the company was incorporated in 1995. Now, โฆSee details»
Sunol Molecular - Funding, Financials, Valuation & Investors
Jan 1, 2000 Organization. Sunol Molecular . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Funding. Sunol Molecular has โฆSee details»
HCW Biologicsโ Founder and CEO Dr. Hing C. Wong Named
Dec 13, 2021 Previously, he founded and served as the CEO of Altor BioScience Corporation (โAltorโ) and Sunol Molecular Corporation. Dr. Wong served as CEO of NantCell following the โฆSee details»
ALT 836 - AdisInsight - Springer
Nov 4, 2017 Originator Sunol Molecular Corporation Developer Altor BioScience Corporation Class Anti-inflammatories; Anticoagulants; Antithrombotics; Monoclonal antibodies ... If your โฆSee details»
Company Profile: Altor BioScience Corporation - Taylor & Francis โฆ
Formed in 2002 as a spin-off from Sunol Molecular Corporation. Altor is utilizing its novel Soluble T-Cell Antigen Receptor (STARโข) platform technology to capture the precise, disease โฆSee details»
Anti-Shiga toxin monoclonal antibodies(Sunol Molecular Corp.)
ABSTRACT Shiga toxin-producing Escherichia coli infections are difficult to treat due to the risk of antibiotic-induced stress upregulating the production of toxins, medical treatment is โฆSee details»
Sunol Molecular - Drug pipelines, Patents, Clinical trials - Synapse
Aug 9, 2024 Explore Sunol Molecular with its drug pipeline, therapeutic area, technology platform, 3 literature, Drug:Single chain T cell receptors (Sunol Molecular). Biomedical โฆSee details»
Multimodal beneficial effects of BNN27, a nerve growth factor
5 days ago The allomorph with the longest length Aฮฒ42 tends to form higher molecular weight oligomers than the other isoforms, followed by conversion to protofibrils and mature fibrils, โฆSee details»